PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
This activity is not new as tagged by the database - it is a continuation of Funding Mechanism 7406.08,
Activity ID 16308.08.
The Infectious Diseases Institute (IDI) is a Uganda-registered NGO, owned by Makerere University. It has
an independent Board led by the Dean of the Faculty of Medicine. IDI has trained 2,394 course participants
from 26 African countries in the areas of HIV/AIDS, malaria, pharmacy, lab and data management. Twenty-
six research projects are in progress, focusing on identifying best practices and models for prevention, care
and treatment of HIV/AIDS and related infectious diseases in sub-Saharan Africa. Almost 9,000 people are
receiving care at the IDI clinic, and 5,741 people are on anti-retroviral therapy (ART). In addition, a total of
3,004 people are being cared for at four Kampala City Council clinics supported by IDI, and 1,339 people
are receiving ART across the four sites.
In August 2008, IDI was awarded a CDC Cooperative Agreement to build capacity for scaling up of
HIV/AIDS services in Kibaale and Kiboga, two rural underserved and high prevalence districts in Uganda.
IDI intends to implement this service in conjunction with the respective District Health Offices, The AIDS
Support Organization (TASO) and Strengthening Counselor Training (SCOT) projects. These latter two
organizations will support the HIV/AIDS Care and treatment and training functions respectively. Specifically
the project will: (1) establish and manage routine confidential HIV counseling and testing services for all
patients; (2) provide comprehensive clinical care for persons with HIV, including staff, through provision of
basic palliative care services and ART to eligible clients; and (3) support the capacity of the target health
facilities to provide comprehensive HIV/AIDS care services through appropriate training, networking,
information exchange and planning.At the end of the project period, IDI will have scaled-up routine HIV
Counseling and Testing in at least six health facilities and tested 200,000 people. In addition, the project will
provide at least 3,000 HIV-infected people with a care package and to start or maintain at least 1,500 HIV-
positive people on ART. Other measurable outcomes include training for at least 200 health workers in
comprehensive HIV/AIDS Care and starting 900 HIV+ people on TB treatment.
In FY 2009, IDI and its partners will provide adult care and treatment services at the 6 centres in Kibaale
and Kiboga districts. All the 10,000 active adult clients will be facilitated to access a comprehensive
package of high quality Adult Care & Treatment services. The Adult Care & Treatment package will
comprise of: counseling for clients and family members; provision of antiretroviral therapy (ART); screening
and treating opportunistic infections; screening and treating sexually transmitted infections (STI); providing
vital information on cotrimoxazole prophylaxis, safe water, nutrition, STI, FP, PMTCT; enrolling clients on
cotrimoxazole prophylaxis; providing safe water vessels and promoting safe water use; providing LLITNs
and promoting malaria prevention; providing condoms to sexually active clients; conducting various courses
to train service providers to provide HIV care and support; and procurement/provision of nutritional
supplements for clients. In order to reach the targeted beneficiaries, IDI and its main parter TASO, will
provide Adult Care & Treatment through various venues and using appropriate and proven service delivery
models. The broad service delivery strategies will include mobilization and sensitization, capacity-building,
beneficiary involvement, greater PHA involvement, partnership and collaboration and others. In partnership
with PSI and TASO, IDI will provide a basic care kit consisting of safe water vessels and chlorine solution
(Waterguard®), LLITNs (bed nets) for prevention of mosquito bites, cotrimoxazole prophylaxis and condoms
to sexually active clients. The targets for the basic care kit be: 3,000 clients given water vessels and
chlorine solution for preventing contamination of drinking water by pathogenic organisms thereby preventing
water borne diseases like diarrhea; 3,000 clients given LLITNs to prevent malaria which is Uganda's highest
cause of mortality and morbidity; all adult clients will have the option to access condoms as part of their kits
and the sexually active clients will be empowered to appreciate, access and use condoms correctly and
consistently; and 3,000 new clients will be provided with cotrimoxazole prophylaxis. IDI in conjunction with
TASO will continue sensitizing clients on the importance of the various Care & Treatment services in
improving the quality of clients' lives. Sensitization will be done through counseling, health education talks,
MDD performances and IEC materials at all service outlets. Staff at the 11 Centres will educate clients on
various Care & Treatment issues through individual and group sessions. The IDI project field teams will
monitor use of Care & Treatment services during regular visits to clients' homes. IDI will provide STI
information to all adolescents and adult clients with emphasis on sexually active clients. All sexually active
clients will be screened for STI routinely and all clients will be screened for STI at least twice a year. All
clients diagnosed with STI will be counseled, treated for STI, supported to mobilize sexual partners for STI
treatment, provided with condoms and condom education. Field teams at the 6 facilities will follow up
specific STI cases and refer for specialized care where necessary. Teams will support clients to uphold the
high adherence levels and will support clients with low adherence through follow-up. Quality assurance of
services will be done through ensuring conformity with national and international standards, conducting
regular refresher training for service providers, rigorous support supervision of service providers, technical
support visits to service outlets and teams, conducting regular QA meetings in service delivery departments
and conducting regular client satisfaction feedback exercises.
New/Continuing Activity: New Activity
Continuing Activity:
Emphasis Areas
Gender
* Addressing male norms and behaviors
* Increasing gender equity in HIV/AIDS programs
Health-related Wraparound Programs
* Child Survival Activities
* Family Planning
* Malaria (PMI)
* Safe Motherhood
* TB
Human Capacity Development
Public Health Evaluation
Food and Nutrition: Policy, Tools, and Service Delivery
Food and Nutrition: Commodities
Economic Strengthening
Education
Water
Estimated amount of funding that is planned for Water $20,000
Table 3.3.08:
This PHE activity, 'Change Agents Program,' was approved for inclusion in the COP. The PHE tracking ID
associated with this activity is UG.08.0171.
Estimated amount of funding that is planned for Public Health Evaluation $100,000
New/Continuing Activity: Continuing Activity
Continuing Activity: 21592
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
21592 21592.08 HHS/Centers for Infectious Disease 12197 12197.08 Expansion of $650,000
Disease Control & Institute Routine HCT
Prevention and provision of
Basic Care in
Clinics,
Hospitals and
HC IVs
Table 3.3.09:
In FY 2009, IDI and its partners will support TB/HIV integration activities across 6 health facilities in Kibaale
and Kiboga districts. The aim of this funding will be to screen 3,000 patients for TB and provide TB/HIV
integrated care to 920 TB-HIV co-infected individuals. To ensure sustainability of services, IDI and its
partners will support the improvement of existing structures and systems within the health facilities. An
assessment will be conducted to identify areas that will need priority actions. The assessment will examine
factors such as the availability of laboratory staff and their level of training/experience, the number and
types of laboratory services currently available (with an emphasis on HIV/AIDS and TB diseases), current
infrastructure (quality of testing tools, and other non-expendable equipment), availability of supplies
(reagents and protective gear) and supply-chain, availability of operating procedures and protocols for
laboratory management and performance, and the level of resources allocated to laboratory performance by
district planning committees. From the assessment, a plan to address the gaps identified will be developed
according to MOH guidelines and implemented in collaboration with the National TB and Leprosy Program.
Finally in working with the district education and communication (IEC) teams, the program will provide
support for a communications campaign aimed at increasing TB-DOTS and ART literacy in target health
facilities and the surrounding communities. Health facility staff will be supported in data management and
analysis to enable them to better monitor adherence to relevant treatment regimes and to track progress in
the performance of their activities. The respective District Health Offices will ensure a constant supply of TB
drugs, septrin and ARVs to TB/HIV co-infected patients. Support supervision and on-job training will
strengthen TB/HIV integrated services.
Continuing Activity: 16312
16312 16312.08 HHS/Centers for Infectious Disease 12197 12197.08 Expansion of $130,000
Table 3.3.12:
In FY 2009, IDI and its partners will support the implementation of routine HIV counseling and testing in 6
district and lower level facilities. This activity proposes to reach 100,000 unique individuals with CT services
between 1st October 2009 and 30th September 2010. In FY 2010, the same targets will be reached. In-
service training and technical support supervision will be provided by project staff health workers in the
health facilities. IDI will identify and strengthen facility-based counselor supervisors who will continue to
provide technical support in this area to the other health workers. Quality Assurance for the counseling and
testing process will be emphasized and external quality control for HIV testing will be conducted. The
project will also train and provide technical support supervision to adhere to guidelines related to proper
management and disposal of medical waste. Standard operating procedures and protocols for
implementation of RCT and waste disposal will be distributed to the new sites. IDI's support will focus
primarily on providing materials for managing medical waste at the point of waste generation (testing points
and wards). IDI will also support the setting up of, or strengthening of clinic-based support groups and post-
test clubs to assist in providing post-test counseling and psychosocial support to persons who test for HIV.
Health workers will be equipped to support clients who need couple counseling, disclosure of HIV testing
results to partners and support for discordant couples. In the case of infant testing and testing for pregnant
women, the program will partner with other implementing agencies working in this area especially the
Pediatric Infectious Diseases Clinic (PIDC), EGPAF and Protecting Families Against HIV/AIDS (PREFA) to
provide CT services to children. IDI support in these areas will be varied depending on level of presence of
PIDC, EGPAF, PREFA and/or similar partners in the supported facilities. In each case, the roles of the
various partners will be delineated to avoid duplication of support. IDI will work closely with the district
health teams and health unit CT focal persons to enhance ownership and sustainability of the service, and
to increase its utilization. IDI will also produce IEC materials on routine CT in English and the various local
languages used in the focus areas, which will be disseminated in the health facilities, to community leaders
and clients. IDI will collaborate with MOH, National Medical Stores (NMS) and Supply Chain Management
Systems (SCMS) to strengthen logistics management to minimize stock-outs. Technical support will also be
provided to improve collection, analysis, distribution and use of data on RCT so as to inform and improve
program activities.
Continuing Activity: 16303
16303 16303.08 HHS/Centers for Infectious Disease 12197 12197.08 Expansion of $480,000
* Increasing women's legal rights
Table 3.3.14:
In FY 2009, IDI and its partners will conduct activities under ARV Drugs to support HIV treatment services
by the 6 facilities in Kibaale and Kiboga districts. The ARV Drugs related activities will comprise of:
procuring buffer stocks of ARVs for the GOU/MOH ART accredited sites when the need arises. In addition,
MOH accredited sites will be supported to procure ARV drugs for prophylaxis for 200 eligible pregnant
women and their newborn babies; maintaining a primary buffer stock of ARV drugs covering at least 3
months at each of the 6 facilities; maintaining and regularly updating the 12 month rolling forecast for ARV
drugs; ensuring professional stores and stock control practices for ARV drugs; maintaining a computerized
stores information management system for ARV drugs integrated with drug consumption information
systems; training/re-training pharmacy and stores personnel; and liaising with ARV drug supply partners to
keep abreast with critical market trends. The ARV Drugs program area is related to the program areas of
PMTCT, Palliative Care (Basic), Palliative Care (TB/HIV), Counseling & Testing, ARV Services and
Laboratory Infrastructure.
Continuing Activity: 21591
21591 21591.08 HHS/Centers for Infectious Disease 12197 12197.08 Expansion of $400,000
* Reducing violence and coercion
Table 3.3.15:
